Vincent Dollard, (404) 778-4580
ATLANTA -- Jonathan Simons, MD, Director of the Winship Cancer Institute of Emory University, has announced the appointment of Nabil Saba, MD, as Assistant Professor of Hematology and Oncology and Director of House Staff Education Programs.
Dr. Saba comes to the WCI from the Hennepin County Medical Center in Minneapolis, MN, where he served as Director of Cancer Research and Assistant Professor of Medicine at the University of Minnesota. He is Board Certified in Internal Medicine and in Hematology and Oncology.
Dr. Saba’s primary assignment will be at the WCI’s new facility at Emory Crawford Long Hospital. He will also provide service to Grady Hospital and the Atlanta VA Medical Center.
Dr. Saba’s areas of clinical interest include bone marrow transplantation, hematologic malignancies as well as lung cancer and gastrointestinal malignancies. His areas of interest in cancer research include multiple myeloma, lung cancer and primary systemic amyloidosis, which is an imbalance in which high levels of protein substances are deposited within the body's tissues in the form of microscopic fibers called fibrils. Many different forms of primary systemic amyloidosis have been recognized, including multiple myeloma.
Fadlo Khuri, MD, Associate Director for Clinical and Translational Research at WCI and Director of WCI’s Aerodigestive Tract Cancer Program, said that Dr. Saba’s recruitment helps solidify WCI and Emory as one of the premier sites in the Southeast for patient-centered care. "Dr. Saba brings to Winship an extremely high level of excellence in patient care and education, having published extensively in peer reviewed scientific journals. He also brings to WCI a deeply held belief that our patients deserve the absolute best care that we can provide for them. He is a wonderful addition to our growing faculty here at WCI."
Dr. Saba received his Doctor of Medicine degree from American University of Beirut, Medical School in Beirut, Lebanon. His postdoctoral training included a residency in Internal Medicine at Tufts University School of Medicine in Boston, and Clinical Fellowships in Hematology and Oncology at Brown University School of Medicine and in Bone Marrow Transplant at the University of Toronto Princess Margaret Hospital in Toronto, Canada.
While at the University of Minnesota, Dr. Saba developed and implemented curricula for teaching oncology fellows and residents. He was recognized by the University of Minnesota’s Hematology, Oncology and transplant division for his outstanding contributions to the fellowship program. He will work to develop a similar program at WCI and will participate in development of a Molecular and Clinical Hematology and Oncology course through the Emory University School of Medicine. Dr. Saba will also provide teaching seminars to fellows and staff at Emory Crawford Long and Grady Hospitals.
"I am excited to join the WCI as I believe it offers a unique environment for translating scientific research into exceptional care of our patients," said Dr. Saba. "At Crawford Long we will be working at initiating and expanding an academically oriented group practice that will accrue patients to WCI clinical trials. We will also develop new trials in the areas of solid tumors--namely lung cancer and GI malignancies, and at Grady Health System we will focus on hematologic malignancies."
"We are very excited that Dr. Saba will join our team at WCI," said Dr. Simons. "He brings outstanding talents as a clinician, investigator and teacher to our new translational cancer center."